Market Research Logo

AFFiRiS AG - Product Pipeline Review - 2016

AFFiRiS AG - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘AFFiRiS AG - Product Pipeline Review - 2016’, provides an overview of the AFFiRiS AG’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by AFFiRiS AG, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of AFFiRiS AG
The report provides overview of AFFiRiS AG including its business description, key facts, and locations and subsidiaries
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report assesses AFFiRiS AG’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report features AFFiRiS AG’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate AFFiRiS AG’s strategic position with total access to detailed information on its product pipeline
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for AFFiRiS AG
Identify potential new clients or partners in the target demographic
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding AFFiRiS AG’s pipeline depth and focus of pipeline therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Table of Contents
List of Tables
List of Figures
AFFiRiS AG Snapshot
AFFiRiS AG Overview
Key Information
Key Facts
AFFiRiS AG - Research and Development Overview
Key Therapeutic Areas
AFFiRiS AG - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
AFFiRiS AG - Pipeline Products Glance
AFFiRiS AG - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
AFFiRiS AG - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
AFFiRiS AG - Drug Profiles
ATH-03
Product Description
Mechanism of Action
R&D Progress
ATH-04
Product Description
Mechanism of Action
R&D Progress
ATH-06
Product Description
Mechanism of Action
R&D Progress
PD-01
Product Description
Mechanism of Action
R&D Progress
PD-03
Product Description
Mechanism of Action
R&D Progress
AD-05
Product Description
Mechanism of Action
R&D Progress
ATH-05
Product Description
Mechanism of Action
R&D Progress
PD-04
Product Description
Mechanism of Action
R&D Progress
Vaccine for Allergic Rhinitis and Asthma
Product Description
Mechanism of Action
R&D Progress
Vaccine for Huntington's Disease
Product Description
Mechanism of Action
R&D Progress
Vaccine for Type 2 Diabetes
Product Description
Mechanism of Action
R&D Progress
Vaccine to Target C5a for Alzheimer's Disease
Product Description
Mechanism of Action
R&D Progress
Vaccine to Target PCSK9 for Hypercholesterolemia
Product Description
Mechanism of Action
R&D Progress
AFFiRiS AG - Pipeline Analysis
AFFiRiS AG - Pipeline Products by Target
AFFiRiS AG - Pipeline Products by Route of Administration
AFFiRiS AG - Pipeline Products by Molecule Type
AFFiRiS AG - Recent Pipeline Updates
AFFiRiS AG - Dormant Projects
AFFiRiS AG - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
AFFiRiS AG, Key Information
AFFiRiS AG, Key Facts
AFFiRiS AG - Pipeline by Indication, 2016
AFFiRiS AG - Pipeline by Stage of Development, 2016
AFFiRiS AG - Monotherapy Products in Pipeline, 2016
AFFiRiS AG - Phase I, 2016
AFFiRiS AG - Preclinical, 2016
AFFiRiS AG - Pipeline by Target, 2016
AFFiRiS AG - Pipeline by Route of Administration, 2016
AFFiRiS AG - Pipeline by Molecule Type, 2016
AFFiRiS AG - Recent Pipeline Updates, 2016
AFFiRiS AG - Dormant Developmental Projects,2016
List of Figures
AFFiRiS AG - Pipeline by Indication, 2016
AFFiRiS AG - Pipeline by Stage of Development, 2016
AFFiRiS AG - Monotherapy Products in Pipeline, 2016
AFFiRiS AG - Pipeline by Target, 2016
AFFiRiS AG - Pipeline by Molecule Type, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report